id:"swepub:oai:DiVA.org:liu-73914"
Sökning: id:"swepub:oai:DiVA.org:liu-73914" > Time trends in STEM...
- 1 av 1
- Föregående post
- Nästa post
- Till träfflistan
| Fältnamn | Indikatorer | Metadata |
|---|---|---|
| 000 | 04426naa a2200409 4500 | |
| 001 | oai:DiVA.org:liu-73914 | |
| 003 | SwePub | |
| 008 | 120116s2012 | |||||||||||000 ||eng| | |
| 024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-739142 URI |
| 024 | 7 | a https://doi.org/10.1136/bmjopen-2011-0007262 DOI |
| 040 | a (SwePub)liu | |
| 041 | a engb eng | |
| 042 | 9 SwePub | |
| 072 | 7 | a ref2 swepub-contenttype |
| 072 | 7 | a art2 swepub-publicationtype |
| 100 | 1 | a Sederholm Lawesson, Sofiau Östergötlands Läns Landsting,Linköpings universitet,Kardiologi,Hälsouniversitetet,Kardiologiska kliniken US4 aut0 (Swepub:liu)sofla80 |
| 245 | 1 0 | a Time trends in STEMI—improved treatment and outcome but still a gender gap :b a prospective observational cohort study from the SWEDEHEART register |
| 264 | c 2012-03-27 | |
| 264 | 1 | b BMJ,c 2012 |
| 338 | a electronic2 rdacarrier | |
| 520 | a Objective In ST elevation myocardial infarction women received less evidence-based medicine and had worse outcome during the fibrinolytic era. With the shift to primary percutaneous coronary intervention (pPCI) as preferred reperfusion strategy, the authors aimed to investigate whether these gender differences has diminished.Design, setting and participants Cohort study including consecutive ST elevation myocardial infarction patients registered 1998–2000 (n=15 697) and 2004–2006 (n=14 380) in the Register of Information and Knowledge about Swedish Heart Intensive care Admissions.Outcome measures 1. Use of evidence-based medicine such as reperfusion therapy (pPCI or fibrinolysis) and evidence-based drugs at discharge. 2. Inhospital and 1-year mortality.Results Of those who got reperfusion therapy, pPCI was the choice in 9% in the early period compared with 68% in the late period. In the early period, reperfusion therapy was given to 63% of women versus 71% of men, p<0.001. Corresponding figures in the late period were 64% vs 75%, p<0.001. After multivariable adjustments, the ORs (women vs men) were 0.86 (95% CI 0.78 to 0.94) in the early and 0.80 (95% CI 0.73 to 0.89) in the late period. As regards evidence-based secondary preventive drugs at discharge in hospital survivors (platelet inhibitors, statins, ACE inhibitors/angiotensin receptor blockers and β-blockers), there were small gender differences in the early period. In the late period, women had 14%–25% less chance of receiving these drugs, OR 0.75 (95% CI 0.68 to 0.81) through 0.86 (95% CI 0.73 to 1.00). In both periods, multivariable-adjusted inhospital mortality was higher in women, OR 1.18 (95% CI 1.02 to 1.36) and 1.21 (1.00 to 1.46). One-year mortality was gender equal, HR 0.95 (95% CI 0.87 to 1.05) and 0.96 (0.86 to 1.08), after adding evidence-based medicine to the multivariable adjustments.Conclusion In spite of an intense gender debate, focus on guideline adherence and the change in reperfusion strategy, the last decade gender differences in use of reperfusion therapy and evidence-based therapy at discharge did not decline during the study period, rather the opposite. Moreover, higher mortality in women persisted. | |
| 650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
| 650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
| 653 | a ST-elevation myocardial infarction | |
| 653 | a sex factors | |
| 653 | a reperfusion therapy | |
| 653 | a mortality | |
| 653 | a evidence-based medicine | |
| 700 | 1 | a Alfredsson, Joakimu Östergötlands Läns Landsting,Linköpings universitet,Kardiologi,Hälsouniversitetet,Kardiologiska kliniken US4 aut0 (Swepub:liu)joaal38 |
| 700 | 1 | a Fredrikson, Matsu Linköpings universitet,Yrkes- och miljömedicin,Hälsouniversitetet4 aut0 (Swepub:liu)matfr43 |
| 700 | 1 | a Swahn, Evau Östergötlands Läns Landsting,Linköpings universitet,Kardiologi,Hälsouniversitetet,Kardiologiska kliniken US4 aut0 (Swepub:liu)evasw45 |
| 710 | 2 | a Linköpings universitetb Kardiologi4 org |
| 773 | 0 | t BMJ Opend : BMJg 2:2q 2:2x 2044-6055 |
| 856 | 4 | u https://liu.diva-portal.org/smash/get/diva2:478618/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
| 856 | 4 | u https://bmjopen.bmj.com/content/2/2/e000726.full.pdf |
| 856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-73914 |
| 856 | 4 8 | u https://doi.org/10.1136/bmjopen-2011-000726 |
- 1 av 1
- Föregående post
- Nästa post
- Till träfflistan
Hitta mer i SwePub
- Av författaren/redakt...
- Sederholm Lawess ...
- Alfredsson, Joak ...
- Fredrikson, Mats
- Swahn, Eva
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
- MEDICIN OCH HÄLS ...
- och Klinisk medicin
- och Kardiologi
- Artiklar i publikationen
- BMJ Open
- Av lärosätet
- Linköpings universitet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
